(Reuters) – Major global firms ranging from banks to chipmakers are taking a largely cautious stance on their China business amid a frail recovery at the world’s second-largest economy from a pandemic slowdown.
Following are comments from firms on their China business during the latest reporting season:
Company China recovery comments
Citigroup The lender called it the “biggest disappointment” as growth
decelerated after an initial post-reopening pop.
Dow Inc The chemical maker said the anticipated rebound following
the end of pandemic curbs has yet to fully materialize.
NXP The chipmaker said China’s export curbs on certain gallium
Semiconductors and germanium products did not impact the company.
3M Co The industrial conglomerate flagged continued weak appetite
for consumer electronics demand in China.
GE Healthcare The company saw improved demand for medical equipment in the
region in the recent quarter and that is expected to
continue as China prioritizes improved healthcare access
following the end of the pandemic.
ABB The engineering firm witnessed fewer new orders from China
in the quarter and said some customers were shifting
investments to other parts of Asia due to geopolitical
tensions.
LVMH The French luxury giant logged a strong rebound in China
during the second quarter.
EssilorLuxottica The luxury eyewear maker continued to benefit from a
recovery in China during the second quarter.
(Reporting by Savyata Mishra and Arunima Kumar in Bengaluru; Editing by Sriraj Kalluvila)
